SecBot SecBot
144 ·Filed May 18, 2026

ARTV

Artiva Biotherapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed6mo ago SEC0001621152-26-000003
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine sell-to-cover transaction for tax withholding upon RSU vesting, not a discretionary insider sale. No bearish signal. Monitor for any subsequent open-market selling by insiders, which would be more informative. No trading action warranted.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$8.55
T+0 close · May 18, 2026 · via day close
Latest settled
+32.16%
T+60 · $11.30
Vs SPY
+25.87%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 19 $8.55entry
  2. T+1 · 6mo ago −8.30%α −9.34% · $7.84
  3. T+5 · 6mo ago −10.76%α −13.06% · $7.63
  4. T+20 · 5mo ago +16.26%α +15.27% · $9.94
  5. T+60 · 3mo ago +32.16%α +25.87% · $11.30

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Jennifer Bush, an officer and director of Artiva Biotherapeutics, filed a Form 144 to sell 9,000 shares of common stock as a sell-to-cover transaction for taxes owed on recently vested restricted stock units. At current market cap of ~$242M, this is a small, routine transaction with no material fundamental signal.

Key Facts

  • Jennifer Bush (Officer/Director) filed Form 144 on 5/18/2026 proposing to sell 9,000 shares of Artiva Biotherapeutics (ARTV).
  • The sale is explicitly a 'sell-to-cover transaction for taxes owed related to recent vesting of stock unit awards', not a discretionary open-market sale.
  • Total estimated proceeds from the sale are immaterial relative to the company's ~$242M market cap.
  • The shares were acquired via vesting of restricted stock units on 5/15/2026 as compensation for services.

Financial Impact

9,000 shares at ~$27/share implied by $242M market cap over ~9M shares outstanding is approximately $243K, a de minimis amount.

insider holdingsdilution

Risk Factors

  • Lock-up or quiet-period implications not disclosed, general SEC Rule 144 requirements apply.
  • If the company enters a material event window (earnings, data readout), this pre-scheduled tax sale could appear poorly timed, but the filing explicitly attributes it to tax obligations.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
92% bullish (12 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001621152-26-000003
Document: 0001621152-26-000003-index.html0001621152-26-000003
Document: 0001621152-26-000003.txt0001621152-26-000003

Track record

33 reports on ARTV

Performance horizon

11 of 16 bullish or bearish reports moved the stock their way by T+20. Best: +66.32% at T+60 after the Jun 8, 2026 report. 17 of 19 went positive at some point.

Filters
  1. Nov 9, 20267d ago 8-K/A Bearish 7/10 Entry $4.06 Now $3.96 +2.46% settles Dec 9
  2. Nov 3, 202613d ago Insider Cluster Bearish 6/10 Entry $4.22 Now $3.96 +6.16% settles Dec 3
  3. Oct 27, 202620d ago 8-K Bearish 6/10 Entry $4.27 Now $3.96 +7.26% settles Nov 24
  4. Oct 6, 20265w ago 144 Neutral 3/10 Entry $7.00 to $4.21 Now $3.96 −43.43% ▼ −39.93% −38.69% vs SPY
  5. Sep 11, 20269w ago 8-K Neutral 3/10 Entry $10.14 to $6.77 Now $3.96 −60.95% ▼ −33.23% −35.50% vs SPY
  6. Sep 9, 20269w ago Insider Cluster Neutral 4/10 Entry $10.42 to $6.80 Now $3.96 −62.00% ▼ −34.74% −37.12% vs SPY
  7. Sep 9, 20269w ago Insider Cluster Neutral 3/10 Entry $10.42 to $6.80 Now $3.96 −62.00% ▼ −34.74% −37.12% vs SPY
  8. Sep 9, 20269w ago Insider Cluster Neutral 4/10 Entry $10.42 to $6.80 Now $3.96 −62.00% ▼ −34.74% −37.12% vs SPY
  9. Sep 9, 20269w ago Insider Cluster Neutral 3/10 Entry $10.42 to $6.80 Now $3.96 −62.00% ▼ −34.74% −37.12% vs SPY
  10. Sep 9, 20269w ago Insider Cluster Bearish 5/10 Entry $10.42 to $6.80 Now $3.96 +62.00% ▲ +34.74% +37.12% vs SPY
Showing 10 of 33

US Market Status

Market Closed · Opens in 8h 4m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 18, 2026